Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J HIRSH

Showing results (331-340 of 666) with videos related to

Pageof 67
Sort By:
Thrombosis Research|February 1, 1980
The thrombogenicity of prothrombin complex concentrates: II. The effect of thrombocytopenia on in vivo thrombogenicity in rabbitsA R Giles, H Hoogendoorn, M A Blajchman, et al.
Thrombosis Research|February 1, 1980
Simplification of the sequential impedance plethysmograph technique without loss of accuracyD W Taylor, R Hull, D L Sackett, et al.
Blood|March 1, 1982
Sex related differences in platelet function: the effect of aspirinJ G Kelton, C J Carter, A Santos, et al.
Thrombosis Research|May 1, 1980
A comparison of the quantitative ristocetin von Willebrand factor assay by using fresh and fixed plateletsJ G Kelton, J Bishop, C J Carter, et al.
Thrombosis Research|November 1, 1982
Discordance between the anti-Xa activity and the antithrombotic activity in an ultra-low molecular weight heparin fractionP A Ockelford, C J Carter, L Mitchell, et al.
Archives of Internal Medicine|May 1, 1986
Combined tubular dysfunction in medullary cystic diseaseA Chagnac, D Zevin, T Weinstein, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|June 1, 1996
Multicentric evaluation of heparinase on aPTT, thrombin clotting time and a new PT reagent based on recombinant human tissue factorJ Harenberg, T Reichel, R Malsch, et al.
The Journal of Biological Chemistry|April 27, 2000
Type II cAMP-dependent protein kinase-deficient Drosophila are viable but show developmental, circadian, and drug response phenotypesS K Park, S A Sedore, C Cronmiller, et al.
Circulation|June 20, 2001
Guide to anticoagulant therapy: Heparin : a statement for healthcare professionals from the American Heart AssociationJ Hirsh, S S Anand, J L Halperin, et al.
Circulation|November 1, 1993
Heparin binding proteins. Contribution to heparin rebound after cardiopulmonary bypassK H Teoh, E Young, C A Bradley, et al.
Pageof 67

Showing results (331-340 of 666) with videos related to

Sort By:
Pageof 67
Thrombosis Research|February 1, 1980
The thrombogenicity of prothrombin complex concentrates: II. The effect of thrombocytopenia on in vivo thrombogenicity in rabbitsA R Giles, H Hoogendoorn, M A Blajchman, et al.
Thrombosis Research|February 1, 1980
Simplification of the sequential impedance plethysmograph technique without loss of accuracyD W Taylor, R Hull, D L Sackett, et al.
Blood|March 1, 1982
Sex related differences in platelet function: the effect of aspirinJ G Kelton, C J Carter, A Santos, et al.
Thrombosis Research|May 1, 1980
A comparison of the quantitative ristocetin von Willebrand factor assay by using fresh and fixed plateletsJ G Kelton, J Bishop, C J Carter, et al.
Thrombosis Research|November 1, 1982
Discordance between the anti-Xa activity and the antithrombotic activity in an ultra-low molecular weight heparin fractionP A Ockelford, C J Carter, L Mitchell, et al.
Archives of Internal Medicine|May 1, 1986
Combined tubular dysfunction in medullary cystic diseaseA Chagnac, D Zevin, T Weinstein, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|June 1, 1996
Multicentric evaluation of heparinase on aPTT, thrombin clotting time and a new PT reagent based on recombinant human tissue factorJ Harenberg, T Reichel, R Malsch, et al.
The Journal of Biological Chemistry|April 27, 2000
Type II cAMP-dependent protein kinase-deficient Drosophila are viable but show developmental, circadian, and drug response phenotypesS K Park, S A Sedore, C Cronmiller, et al.
Circulation|June 20, 2001
Guide to anticoagulant therapy: Heparin : a statement for healthcare professionals from the American Heart AssociationJ Hirsh, S S Anand, J L Halperin, et al.
Circulation|November 1, 1993
Heparin binding proteins. Contribution to heparin rebound after cardiopulmonary bypassK H Teoh, E Young, C A Bradley, et al.
Pageof 67